Work

Rituximab, Lenalidomide, and Bortezomib in the First-Line or Second-Line Treatment of Patients with Mantle Cell Lymphoma a Phase I/II Trial.

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.2748.2748

Authors: Ian W. Flinn, Mark Mainwaring, Nancy Peacock, Dianna Shipley, Edward Arrowsmith, Michael R. Savona, John D. Hainsworth, Jesus G. Berdeja

Institutions: Tennessee Oncology, Sarah Cannon

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2577306999

FWCI: 1.613

Cites:

Cited by: 16

Related to: 10